Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
81. |
ECCT/23/12/02 | PEARL RSVt Vaccine Study Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL) |
Principal Investigator(s) 1. Dr. Maricianah Onono Site(s) in Kenya 1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county) 2. Walter Reed Army Institute of Research -Kericho Site (Kericho county) 3. KEMRI CCR – Butere Clinical Research Centre (Kakamega county) 4. Siaya County Referral Hospital (SCRH) (Siaya county) 5. Kenya Medical Research Institute Center for Microbiology Research (CMR) (Kisumu county) 6. KAVI - Institute of Clinical Research (KAVI - ICR) (Nairobi City county) 7. Kombewa Clinical Research Center, KEMRI, (Kisumu county) |
10-05-2024 |
View |
82. |
ECCT/23/12/01 | PEARL RSVt Vaccine Study Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL) |
Principal Investigator(s) 1. Prof Walter Jaoko 2. Dr. Lucas Thina Otieno 3. Prof. Kariuki Simon 4. Dr. Janet Nyawira Oyieko 5. Walter Otieno 6. Onono Dr. Marcianah 7. Dr. Lucas Thina Otieno 8. Prof. Kariuki Simon 9. Dr. Janet Nyawira Oyieko 10. Walter Otieno 11. Onono Dr. Marcianah Site(s) in Kenya 1. KAVI-Institute of Clinical Research, University of Nairobi (Nairobi City county) 2. Victoria Biomedical Research Institute (VIBRI) (Kisumu county) 3. Walter Reed Army Institute of Research -Kericho Site (Kericho county) 4. KEMRI CCR – Butere Clinical Research Centre (Kakamega county) 5. Siaya County Referral Hospital (SCRH (Siaya county) 6. Kenya Medical Research Institute Center for Microbiology Research (CMR (Kisumu county) 7. Kombewa Clinical Research Center, KEMRI, (Kisumu county) |
02-05-2024 |
View |
83. |
ECCT/23/10/08 | VALUE Placebo Film Study Trial to Assess Acceptability and Safety of Two Placebo Prototype Vaginal Films (MATRIX-002) |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya KEMRI-CCR PHRD Thika |
17-01-2024 |
View |
84. |
ECCT/23/10/06 | CONSTELLATION A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the effect of Bi-26 (strain of Bifidobacterium longum, B. infantis) supplementation versus placebo on weight gain in underweight infants |
Principal Investigator(s) 1. Dr Godfrey Allan Otieno 2. Dr Videlis Nduba Site(s) in Kenya 1. KEMRI-Kondele Children’s Hospital (Kisumu county) 2. KEMRI CRDR Clinical Research Annex (Nairobi City county) |
19-12-2023 |
View |
85. |
ECCT/23/10/03 | PEARL RSVt Vaccine Study Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL) |
Principal Investigator(s) 1. Dr. Lucas Tina, Otieno 2. Prof. Kariuki Simon 3. Dr. Janet Nyawira Oyieko 4. Walter Otieno 5. Onono Dr. Marciana 6. Prof. Walter Jaoko 7. Dr Fredrick Sawe Site(s) in Kenya 1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county) 2. Walter Reed Army Institute of Research -Kericho Site (Kericho county) 3. KEMRI CCR – Butere Clinical Research Centre (Kakamega county) 4. Siaya County Referral Hospital (SCRH (Siaya county) 5. Kenya Medical Research Institute Center for Microbiology Research (CMR (Kisumu county) 6. KAVI - Institute of Clinical Research (KAVI - ICR) (Nairobi City county) 7. Kombewa Clinical Research Center, KEMRI, (Kisumu county) |
12-03-2024 |
View |
86. |
ECCT/23/09/04 | GBT440-038Open-Label Extension An Open-Label Extension Study of Voxelotor Administered Orally to Participants with Sickle Cell Disease Who Have Participated in Voxelotor Clinical Trials |
Principal Investigator(s) 1. Jessie Nyokabi Githanga 2. Videlis Nduba 3. Bernhards Ragama Ogutu Site(s) in Kenya 1. Gertrude’s Children Hospital (Nairobi City county) 2. Kenya Medical Research Institute (KEMRI), Centre for Respiratory Diseases Research (CRDR) (Nairobi City county) 3. KEMRI CRDR SIAYA within Siaya County Referral Hospital Grounds (Siaya county) 4. Strathmore University Medical Center, Centre for Research in Therapeutic Sciences (Nairobi City county) |
12-12-2023 |
View |
87. |
ECCT/23/09/03 | CONSTELLATION A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the effect of Bi-26 (strain of Bifidobacterium longum, B. infantis) supplementation versus placebo on weight gain in underweight infants |
Principal Investigator(s) 1. Dr Simon Kariuki Site(s) in Kenya 1. Kenya Medical Research Institute- Centre for Global Health Research (Kisumu county) |
19-12-2023 |
View |
88. |
ECCT/23/09/01 | ARNASA A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
Principal Investigator(s) 1. Dr Mary Matilu Site(s) in Kenya 1. KEMRI-Mtwapa Clinical Research Annex, (Kilifi county) 2. University of Nairobi Clinical Research Centre (Nairobi City county) 3. Center for Research In Tropical Medicine and Community Development (Nairobi City county) 4. Clinical Research Health Network (CREA-N) (Machakos county) 5. KEMRI-CRDR Siaya Clinical Research Annex (Siaya county) 6. KEMRI-CRDR Clinical Research Annex (Nairobi City county) 7. Clinical Research Health Network (CREA-N) (Machakos county) |
24-11-2023 |
View |
89. |
ECCT/23/08/02 | PRAISE An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease (PRAISE) |
Principal Investigator(s) 1. Nduba Videlis Site(s) in Kenya 1. Getrudes Children Hospital (Nairobi City county) 2. KEMRI/CRDR (Siaya county) 3. Kombewa CRC (Kisumu county) 4. Kondele Childrens Hospital (Kisumu county) |
18-10-2023 |
View |
90. |
ECCT/23/08/01 | ARNASA A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
Principal Investigator(s) 1. Dr Teresa Kinyari Site(s) in Kenya 1. University of Nairobi Clinical Research Centre (Nairobi City county) 2. Center for Research In Tropical Medicine and Community Development (Nairobi City county) 3. Clinical Research Health Network (CREA-N) (Machakos county) 4. KEMRI-CRDR Siaya Clinical Research Annex (Siaya county) 5. KEMRI-Mtwapa Clinical Annex (Kilifi county) 6. KEMRI-CRDR Clinical Research Annex (Nairobi City county) |
06-12-2023 |
View |